Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
440
-
Total 13F shares, excl. options
-
182,744,905
-
Shares change
-
+2,374,906
-
Total reported value, excl. options
-
$17,212,623,295
-
Value change
-
+$242,791,323
-
Put/Call ratio
-
59.24%
-
Number of buys
-
218
-
Number of sells
-
-178
-
Price
-
$94.2
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2018
525 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q2 2018.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 440 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 182,744,905 shares
of 193,539,047 outstanding shares and own 94.42% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (21,593,132 shares), VANGUARD GROUP INC (14,897,053 shares), PRIMECAP MANAGEMENT CO/CA/ (14,240,789 shares), BlackRock Inc. (13,121,259 shares), JENNISON ASSOCIATES LLC (11,588,631 shares), BAKER BROS. ADVISORS LP (7,583,084 shares), SANDS CAPITAL MANAGEMENT, LLC (6,930,199 shares), STATE STREET CORP (3,803,137 shares), Clearbridge Investments, LLC (3,671,489 shares), and Temasek Holdings (Private) Ltd (3,472,712 shares).
This table shows the top 440 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.